Premium
Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance
Author(s) -
McKenzie Shaun,
Kyprianou Natasha
Publication year - 2005
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.20634
Subject(s) - prostate cancer , apoptosis , cancer , cancer research , biology , population , tumor progression , drug resistance , immunology , medicine , genetics , environmental health
The ability of a tumor cell population to grow exponentially represents an imbalance between cellular proliferation and cellular attrition. There is an overwhelming body of evidence suggesting the ability of tumor cells to avoid programmed cellular attrition, or apoptosis, is a major molecular force driving the progression of human tumors. Apoptotic evasion represents one of the true hallmarks of cancer and appears to be a vital component in the immunogenic, chemotherapeutic, and radiotherapeutic resistance that characterizes the most aggressive of human cancers [Hanahan and Weinberg, 2000]. The challenges in the development of effective treatment modalities for advanced prostate cancer represent a classic paradigm of the functional significance of anti‐apoptotic pathways in the development of therapeutic resistance. J. Cell. Biochem. © 2005 Wiley‐Liss, Inc.